Live feed
·
INSIDERFilingvia Quantisnow
Intercept Pharmaceuticals Inc. logo

Intercept Pharmaceuticals (ICPT) executive Berrey received 14,700 shares

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

M Michelle Berrey (executive at Intercept Pharmaceuticals Inc., ICPT) reported that they received 14,700 shares on Jan 27, 2023. After these transactions the filing shows 83,877 shares held directly.

Reporting person
Berrey M Michelle
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jan 27, 2023Grant or award (A)Common Stock1+14,700--83,877 direct

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jan 27, 2023Grant or award (A)Option to Purchase Common StockOn 24,000 Common Stock2+24,000--24,000 direct

Holdings before and after

  • Common Stock: 69,177 to 83,877 direct
  • Option to Purchase Common Stock: 0 to 24,000 direct

Footnotes from the filing

  1. 1. Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2023.
  2. 2. The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2023.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Berrey report in this ICPT Form 4?

M Michelle Berrey (executive at Intercept Pharmaceuticals Inc., ICPT) reported that they received 14,700 shares on Jan 27, 2023. After these transactions the filing shows 83,877 shares held directly.

How many ICPT shares does Berrey hold after this filing?

The filing shows 83,877 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for ICPT

Earlier insider filings at ICPT

Quantisnow market dataNASDAQ
Intercept Pharmaceuticals Inc. logo
ICPT
Intercept Pharmaceuticals Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2012
Get push alerts for ICPT

Follow ICPT and get a push notification the moment its next story breaks.

Full ICPT profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ICPT (Intercept Pharmaceuticals Inc.) and more on Quantisnow.